Skip to main content

Bortezomib

NDC 70511-162 · MAIA Pharmaceuticals, Inc.

Generic namebortezomib

Dosage formINJECTION

RouteINTRAVENOUS

Active ingredient(s)BORTEZOMIB

Strength2.5 mg/1

Pharmacologic classProteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]

Marketing categoryNDA

Packages

70511-162-02 — 1 INJECTION in 1 VIAL, SINGLE-DOSE (70511-162-02)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63323-821 — Bortezomib, 63759-3032 — Bortezomib, 67184-0530 — Bortezomib, 68001-534 — Bortezomib, 68001-540 — Bortezomib, 68001-541 — Bortezomib, 68083-650 — Bortezomib, 68083-651 — Bortezomib, 70069-836 — bortezomib, 70121-2484 — Bortezomib, 70511-161 — bortezomib, 70710-1411 — BORTEZOMIB, 70771-1708 — BORTEZOMIB, 71288-118 — Bortezomib, 72205-183 — Bortezomib, 72338-200 — bortezomib, 72603-270 — Bortezomib, 75007-501 — Bortezomib, 83090-008 — Bortezomib, 83634-208 — bortezomib, +11 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.